# Bioventus Inc. (BVS) stock: price and valuation

URL: https://funkfolio.com/stock/BVS

> Bioventus Inc. (BVS) trades at $10.52, is worth $720.01M, is priced at 13.1× earnings and scores 52/100. Valuation, financials and signals.

---

## Bioventus Inc. (BVS)

Bioventus Inc. (BVS) is a healthcare company (medical devices) based in the United States. The share price is $10.52, up 0.53% on the day, which values the company at $720.01M. Price as of 17 Nov 2026, 20:28 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $10.52 +0.53% today
- **Market value:** $720.01M
- **P/E ratio:** 13.1× last 12 months
- **Forward P/E:** 11.8×
- **Funk Score:** 52/100
- **Against its own history:** Well above its usual price usual price $6.38
- **200-week average:** $7.24 45% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 20:28 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Bioventus Inc. in more detail

BVS trades at 13.1× its last twelve months' earnings, 11.8× next year's expected earnings, 1.2× sales. Measured against its own history, the price is 65% above what its usual multiples would imply ($6.38) — well above its usual price. It sits 45% above its 200-week average of $7.24.

Over the last five fiscal years Bioventus Inc. has compounded revenue 12.1% a year, free cash flow 5.5% a year. Its Funk Score is 52 out of 100 (financial strength 3.4, profitability 5.9, growth 5.2, value 6.1, each out of 10).

In its favour: Strong Piotroski score; Operating margin is expanding. Worth checking: Altman Z in the distress zone; Share count keeps rising.

1 of the superinvestors tracked here hold BVS, including Arnaud Ajdler (0.8% of the portfolio).

### Superinvestors holding BVS

1 of the investors tracked here report a position in their latest 13F filing.

- [Arnaud Ajdler Engine Capital](https://funkfolio.com/gurus/arnaud-ajdler) 0.83% of portfolio · $8.5M · added · Q2 2026

### Bioventus Inc. (BVS): questions and answers

**What is BVS's P/E ratio?**

Bioventus Inc. trades at 13.1× its last twelve months' earnings and 11.8× next year's expected earnings.

**What is BVS's PEG ratio?**

Bioventus Inc.'s PEG ratio is 1.20 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Bioventus Inc.'s market cap?**

Bioventus Inc. is valued at $720.01M at a share price of $10.52.

**Is BVS overvalued or undervalued?**

Against its own history, BVS is well above its usual price: the price is 65% above the $6.38 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is BVS above its 200-week moving average?**

Yes. BVS is 45.1% above its 200-week average of $7.24. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Bioventus Inc. growing?**

Over the last five fiscal years Bioventus Inc.'s revenue grew 12.1% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Bioventus Inc. (BVS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BVS

Underlying data: Yahoo Finance; company filings with the SEC.
